MPMC researchers conducted a survey of pharmacists-in-charge at Minnesota health care systems in September 2018, in order to begin assessing the overall readiness of health organizations in Minnesota to implement pharmacogenomics clinically.
Among the preliminary findings:
- 63% of those surveyed do not have, or have not yet launched, a PGx program in their health system.
- Approximately 52% don’t believe their pharmacy team or their health system has the knowledge needed to implement or maintain a PGx program.
- 67% expect that their organization will increase its use of PGx testing services over the next three years.
- 92% believe that patients served by their health system would benefit from application or increased application of PGx.
- 96% expect it would be moderately or very difficult to develop PGx services in their health system.
- At least 70% of respondents rank insurance reimbursement, patient out-of-pocket costs, clinical decision support systems, clinical expertise and integration into EMR as either moderate, significant or extreme barriers to PGx implementation.
- The two factors identified as most critical to implementing or expanding PGx services were a business plan and PGx education of clinicians.
Download the preliminary results of the full survey here.